State Street’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $299K | Sell |
33,847
-151,275
| -82% | -$1.34M | ﹤0.01% | 3728 |
|
|
2025
Q1 | $1.99M | Sell |
185,122
-2,312
| -1% | -$24.9K | ﹤0.01% | 3249 |
|
|
2024
Q4 | $2.4M | Sell |
187,434
-7,044
| -4% | -$90.2K | ﹤0.01% | 3260 |
|
|
2024
Q3 | $5.37M | Buy |
194,478
+3,562
| +2% | +$98.3K | ﹤0.01% | 2935 |
|
|
2024
Q2 | $5.54M | Buy |
190,916
+5,018
| +3% | +$146K | ﹤0.01% | 2882 |
|
|
2024
Q1 | $8.29M | Buy |
185,898
+8,944
| +5% | +$399K | ﹤0.01% | 2690 |
|
|
2023
Q4 | $6.87M | Sell |
176,954
-163,567
| -48% | -$6.35M | ﹤0.01% | 2784 |
|
|
2023
Q3 | $10M | Buy |
340,521
+31,959
| +10% | +$940K | ﹤0.01% | 2598 |
|
|
2023
Q2 | $19.6M | Sell |
308,562
-87,501
| -22% | -$5.57M | ﹤0.01% | 2257 |
|
|
2023
Q1 | $18.7M | Sell |
396,063
-41,458
| -9% | -$1.96M | ﹤0.01% | 2272 |
|
|
2022
Q4 | $30.4M | Buy |
437,521
+168,529
| +63% | +$11.7M | ﹤0.01% | 1958 |
|
|
2022
Q3 | $39.4M | Buy |
268,992
+139,196
| +107% | +$20.4M | ﹤0.01% | 1769 |
|
|
2022
Q2 | $16.9M | Buy |
129,796
+35,250
| +37% | +$4.6M | ﹤0.01% | 2370 |
|
|
2022
Q1 | $9.55M | Buy |
94,546
+73,587
| +351% | +$7.43M | ﹤0.01% | 2857 |
|
|
2021
Q4 | $3.24M | Buy |
20,959
+6,769
| +48% | +$1.05M | ﹤0.01% | 3453 |
|
|
2021
Q3 | $4.2M | Buy |
+14,190
| New | +$4.2M | ﹤0.01% | 3327 |
|